Article

Real-world clinical results of CGRP monoclonal antibody treatment for medication overuse headache of migraine without abrupt drug discontinuation and no hospitalization

2024-02-27

Abstract excerpt

<h4>Background: </h4> Abrupt discontinuation of overused medications is the gold standard treatment for medication overuse headache (MOH), but discontinuation is difficult to maintain. In this study, the aim was to evaluate the real-world clinical results of anti-calcitonin gene-related peptide monoclonal antibody (CGRP-mAb) treatment for MOH of migraine without abrupt drug discontinuation and no hospitalization....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 78ca0f27-36de-5610-ae74-df9144e216b7
DOI: 10.21203/rs.3.rs-3936391/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Real-world clinical results of CGRP monoclonal antibody treatment for medication overuse headache of migraine without abrupt drug discontinuation and no hospitalizationDOI 10.21203/rs.3.rs-3936391/v1Read

Discontinuing Monoclonal Antibodies Targeting CGRP Pathway After One-Year Treatment: An Observational Longitudinal Cohort StudySemantic proximity Read

Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention in a real world settingSemantic proximity Read

Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UKSemantic proximity Read

Erenumab in highly therapy-refractory migraine patients First German Real-world evidenceSemantic proximity Read

A Descriptive Review of Medication Overuse Headache - from Pathophysiology to the ClinicSemantic proximity Read

Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world DataSemantic proximity Read

Predictors of galcanezumab response in a real-world study of Korean patients with migraineSemantic proximity Read

Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity Read

A Descriptive Review of Medication Overuse HEADACHE-from Pathophysiology to the ClinicSemantic proximity Read

Effectiveness of Switching CGRP monoclonal antibodies in non-responder patients in the UAE: A retrospective studySemantic proximity Read

Reduction of pain and functional disability over time in patients treated with zavegepant: A Post-hoc analysis of the BHV3500-301 Phase 3 Randomized Controlled TrialSemantic proximity Read

Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity Read